Personalized closed-loop non-invasive brain stimulation to treat tics in children
Official title: Clinical Study on a Novel Strategy of Individualized Non-Invasive Neuromodulation for the Treatment of Tic Disorders in Children
Run by Shanghai Children's Medical Center · NCT07351955 · Data updated 2026-11-12
This program will test a personalized, closed-loop transcranial magnetic stimulation (TMS) approach to reduce tics in children and adolescents aged 5 to 18.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Months to 18 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Shanghai Children's Medical Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | May 31, 2026 |
| Study ends | May 31, 2026 |
| Registry record updated | January 20, 2026 |
| Trial ID | NCT07351955 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are treatment‑naive children and adolescents aged 5–18 with DSM-5 tic disorders, normal EEG, FIQ ≥70, right‑handedness, and the ability to undergo MRI/TMS procedures.
✕Probably not a fit
Children with FIQ <70, metal implants, non‑right‑handedness, significant comorbid neurological or psychiatric disorders (e.g., ASD, epilepsy, OCD), prior head trauma, or inability to tolerate MRI/TMS are unlikely to be eligible or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will create a personalized, closed-loop non-invasive brain stimulation protocol using TMS guided by each child's brain activity and imaging, combined with behavioral therapy and safety monitoring. Eligible children (5–18 years) who meet DSM-5 criteria for tic disorders, are treatment‑naive, and have FIQ ≥70 will undergo MRI/fMRI and receive individualized stimulation while clinicians record clinical and neurophysiological outcomes. The protocol excludes participants with metal implants, significant head motion during fMRI, non‑right‑handedness, major neurological or psychiatric comorbidities, or FIQ <70. Outcomes will include changes in tic severity, tolerability, and neural-circuit measures to refine precision neuromodulation for pediatric tics.
Why it matters
Potential benefit: If successful, this approach could offer a more targeted, non-drug way to reduce tic severity and improve daily functioning in affected children.
How similar studies have gone: Conventional TMS has shown mixed results for tics in older patients, while closed-loop, individualized non-invasive stimulation in pediatric tic disorders is largely novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1: Children and adolescents aged 5 to 18 years 2: Meets DSM-5 diagnostic criteria for Tic Disorders (TDs) with normal EEG findings 3: No prior treatment received for TDs 4: Full-scale intelligence quotient (FIQ) ≥70 on the Wechsler Intelligence Scale for Children-Revised (WISC-R) Exclusion Criteria: * 1: WISC-R Full-Scale Intelligence Quotient (FIQ) \<70 2: Presence of metal implants in the body ,Non-right-handedness 3: Head movement (HM) \>2mm during fMRI scanning, including both translational movement (TM) and rotational movement (RM) 4: Any other neurological or psychiatric conditions, including but not limited to autism spectrum disorder (ASD), epilepsy, obsessive-compulsive disorder (OCD), etc 5: Previous head trauma ,Neurological diseases ,Major systemic illnesses
Where it's running
-
Shanghai Children's Medical Center,School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Jun Ma, M.D.
- Email: majun@shsmu.edu.cn
- Phone: 13917230745
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combined ERP and Habit Reversal Therapy for Tourettic OCD
This study tests whether a merged Exposure and Response Prevention and Habit Reversal Therapy helps adults with Tourettic OCD more than either therapy alone or basic psychoeducation.
-
Understanding changes in Tourette Syndrome
This study is trying to learn how Tourette Syndrome and tic disorders change over time in kids by using new technology to track their symptoms.
-
Mindfulness intervention for managing tics in Tourette syndrome
This study is testing a mindfulness program to see if it can help adults with Tourette syndrome manage their tics better than traditional therapy.
-
Comparing Sertraline and Placebo for Treating Anxiety in Children with Neurodevelopmental Disorders
This study is testing if the medication sertraline can help reduce anxiety in children and teens aged 8-17 with neurodevelopmental disorders like autism and Fragile X syndrome compared to a placebo.
-
Characterizing Repetitive Behaviors in OCD and Tic Disorders
This study is testing if special brain activity measurements can help tell the difference between compulsions in OCD and tics in Tourette syndrome to improve treatment options for people aged 15 to 65.
-
Mobile app-assisted treatment for children and adolescents with tics
This study tests whether a mobile app can help children and teens with tic disorders manage their symptoms better and stick to their treatment plans.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.